Connecting you to content on EBSCOhost

Works matching IS 11745886 AND DT 2024 AND VI 24 AND IP 4

Results: 7

1

Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Pop PK and PK/PD Analyses of Pegcetacoplan in PNH: R. L. Crass et al.

Published in:

Drugs in R&D, 2024, v. 24, n. 4, p. 563, doi. 10.1007/s40268-024-00500-7

By:

Crass, Ryan L.;
Smith, Brandon;
Adriaens, Sven;
Chapel, Sunny;
Langdon, Grant

Publication type:

Article

2

Acknowledgement to Referees: Acknowledgement to Referees: Acknowledgement to Referees.

Published in:: Drugs in R&D, 2024, v. 24, n. 4, p. 501, doi. 10.1007/s40268-024-00498-y
Publication type:: Article

3

Pharmacokinetics and Pharmacodynamics of Rusfertide, a Hepcidin Mimetic, Following Subcutaneous Administration of a Lyophilized Powder Formulation in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics of a Lyophilized Formulation of Rusfertide: N. B. Modi et al

Published in:

Drugs in R&D, 2024, v. 24, n. 4, p. 539, doi. 10.1007/s40268-024-00497-z

By:

Modi, Nishit B.;
Khanna, Sarita;
Rudraraju, Sneha;
Valone, Frank

Publication type:

Article

4

In-Use Physicochemical Stability of Sandoz Rituximab Biosimilar in 0.9% Sodium Chloride Solution After Prolonged Storage at Room Temperature Conditions: Stability of Sandoz Rituximab Biosimilar at Prolonged Room Temperature Conditions: R. Borišek et al

Published in:

Drugs in R&D, 2024, v. 24, n. 4, p. 553, doi. 10.1007/s40268-024-00496-0

By:

Borišek, Roman;
Mischo, André;
Foierl, Tobias

Publication type:

Article

5

Bioequivalence Analysis of Ondansetron Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Two-Period Crossover Phase I Study: Bioequivalence Analysis of Ondansetron Hydrochloride Tablets: C. Jia et al.

Published in:

Drugs in R&D, 2024, v. 24, n. 4, p. 531, doi. 10.1007/s40268-024-00493-3

By:

Jia, Caiyun;
Zhao, Na;
Song, Haojing;
Hu, Yiting;
Xu, Yufang;
Guo, Caihui;
Bai, Wanjun;
Dong, Zhanjun

Publication type:

Article

6

Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants: Efgartigimod in Healthy Chinese Participants: S. Jing et al.

Published in:

Drugs in R&D, 2024, v. 24, n. 4, p. 505, doi. 10.1007/s40268-024-00490-6

By:

Jing, Shan;
Zhang, Yu;
Lin, Yang;
Gu, Xiaowen;
Liu, Jing;
Guglietta, Antonio;
Noukens, Jan;
Van Bragt, Tonke;
Wang, Lina;
Chen, Jiajia;
Reinhart, Harald;
Pu, Xia

Publication type:

Article

7

Pharmacokinetics and Bioequivalence of Two Powders of Azithromycin for Suspension: A Nonblinded, Single-Dose, Randomized, Three-Way Crossover Study in Fed and Fasting States Among Healthy Chinese Volunteers: Pharmacokinetics and Bioequivalence of Two Powders of Azithromycin: J. Shao et al

Published in:

Drugs in R&D, 2024, v. 24, n. 4, p. 517, doi. 10.1007/s40268-024-00492-4

By:

Shao, Junbo;
Liu, Xingxing;
Lin, Jing;
Chen, Jiao;
Xie, Xiaoyan

Publication type:

Article